KU-004

N/A

Report date: 2025/01/26 16:29:44
NME

Base Information

Drug NameKU-004
Drug Alias NameKU-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene proteins c-akt modulatorsPI3-kinase class I modulators
TargetsPI3-kinase class IProto-oncogene proteins c-akt
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Kanion Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Kanion Pharmaceutical Co LtdChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A